Research Papers

25 of 564 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Revision cochlear implant surgery for clinical reasons.
Canzano F; Di Lella F; Guida M; Pasanisi E; Govoni M; Falcioni M.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Surgical management of chronic rhinosinusitis with nasal polyps under local anaesthesia: indications and results.
Mimari C; Radulesco T; Penicaud M; Dessi P; Michel J.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Angiotensin-converting enzyme insertion/deletion gene polymorphism in patients with laryngeal cancer.
Kumbul YÇ; Hekimler Öztürk K; Yasan H; Akın V; Sivrice ME; Caner F.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Imaging features of epidermoid cyst located in the floor of the mouth: case report and narrative review of literature.
Basla N; Sfondrini D; Achilli MF; Catalano M; Sanvito F; Sala MG; Marelli S; Benazzo M; Preda L.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation.
Trimarchi M; Vinciguerra A; Rampi A; Tanzini U; Nonis A; Yacoub MR; Bussi M.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Long-term impact of smoking cessation on new glottic cancer events in patients with early glottic cancer.
Kim MS; Wu HG; Sung MW; Kwon TK.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hearing outcomes and patient satisfaction after stapes surgery: local <i>versus</i> general anaesthesia.
Giannoni B; Pollastri F; Adembri C; Straticò D; Vannucchi P; Stival A; Checcucci C; Bruno C; Pecci R.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Determination of costs for the CSRwNP pathway. A time-driven activity-based costing experiment.
Trimarchi M; Foglia E; Schettini F; Bellavia D; Vinciguerra A; Petrone P; Torretta S; Pignataro L.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Free flaps monitoring by Laser-Doppler Flowmetry in head and neck surgery.
Salvatori P; Paradisi S; Zani A.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microdebrider-assisted inferior turbinoplasty <i>versus</i> other surgical techniques.
Kanesan N; Norhayati MN; Hamid SSA; Abdullah B.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Superior temporo-auricular perforator flap for reconstruction of extensive conchal defects.
Parisi P; Ansarin M; Pennacchioli E; Di Meglio F; Ribuffo D; Navach V.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Paediatric otogenic sinus venous thrombosis: the role of <i>Fusobacterium necrophorum</i>.
Yosefof E; Hilly O; Sokolov M; Raveh E; Yacobovich J; Ulanovski D.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The biofilm characteristics and management of skin flap infection following cochlear implantation.
Chen X; Chen Y; Zhang R; Ye S; Lin Z; Nian S; Lin C.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A potential serological biomarker for inner ear pathologies: OTOLIN-1.
Avallone E; Schmitt H; Lilli G; Warnecke A; Lesinski-Schiedat A; Lenarz T; Willenborg K.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Multidimensional voice assessment after Lee Silverman Voice Therapy (LSVT<sup>®</sup>) in Parkinson's disease.
Marchese MR; Proietti I; Longobardi Y; Mari G; Ausili Cefaro C; D'Alatri L.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of video head impulse test during vertiginous attack in vestibular migraine.
Koç A; Akkılıç EC.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Management of pharyngeal collapse in patients affected by moderate obstructive sleep apnoea syndrome.
Lorusso F; Dispenza F; Sireci F; Immordino A; Immordino P; Gallina S.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Serum interleukin 1β in patients with acquired laryngotracheal stenosis.
Azwal N; Lokanathan Y; Azman M; Ng MH; Mohamed AS; Baki MM.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Voice outcomes in patients with advanced laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.
Álvarez-Marcos C; Vicente-Benito A; Gayol-Fernández Á; Pedregal-Mallo D; Sirgo-Rodríguez P; Santamarina-Rabanal L; Llorente JL; López F; Rodrigo JP.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia.
Al Essa M; Doubi A; Aldosari L; Alkhaldi A; Alzahrani M; Alsadi M; Alsalem A.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Italian validation of the Neck Dissection Impairment Index questionnaire.
Marcuzzo AV; Sacchet E; Capriotti V; Gardenal N; Boscolo-Rizzo P; Chepeha DB; Tirelli G.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microsurgical training using an <i>ex-vivo</i> model: microscope <i>vs</i> 3D exoscope.
Molteni G; Ghirelli M; Sacchetto A; Fermi M; De Rossi S; Mattioli F; Presutti L; Marchioni D.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Long-term outcomes and quality of life following parotidectomy for benign disease.
Plath M; Sand M; Cavaliere C; Plinkert PK; Baumann I; Zaoui K.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP.
De Corso E; Baroni S; Onori ME; Tricarico L; Settimi S; Moretti G; Troiani E; Mastrapasqua RF; Furno D; Crudo F; Urbani A; Galli J.
Acta Otorhinolaryngol Ital (Unknown)
Published: 2022
3/6 Transparent
Funding Declared